#Cardiology15
Experimental drug protects hearts in Duchenne muscular dystrophy
A new study found that the experimental drug Setanaxib preserved heart function and reduced scarring in preclinical models of Duchenne muscular dystrophy, and identified the enzyme NOX4 as a possible treatment target.
Photo by Louis Reed, Unsplash
Study links syphilis to serious heart problems
Researchers using New Orleans hospital records found people with later-stage syphilis had higher risks of major cardiovascular events, especially when the infection lasted more than a year. The study shows an association but not proof of cause.
Human heart organoids model atrial fibrillation
Scientists made small, beating human heart‑like organoids from donated stem cells and added immune cells. When they caused inflammation the organoids showed irregular heartbeats like atrial fibrillation; an anti‑inflammatory drug partly restored rhythm.
Cell transplant may help heart after spinal cord injury
Researchers tested transplanting immature nerve cells into spinal cord injuries in rats. The transplants improved nerve control of circulation — stabilizing resting blood pressure and lowering heart rate — but hormonal responses after injury still rose.
Untreated Sleep Apnea Speeds Heart Aging and Raises Death Risk
A laboratory study using a long-term mouse model finds that untreated obstructive sleep apnea — recreated by repeated drops in oxygen during sleep — leads to faster cardiovascular aging and higher mortality. Researchers call for early screening and treatment.
Gene Variant Raises Heart Failure Risk After Myocarditis in Children
A study found that a cardiomyopathy gene variant is more common in children who develop dilated cardiomyopathy after myocarditis. Researchers describe a "double hit" model and advise genetic testing to identify higher risk.